Direct oral anticoagulant for heart failure

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Apr 2023: Trial registered, NCT05825573
  2. 15 May 2023: Trial started, NCT05825573

The trials

NCT05825573: Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

State
Under way
Phase
Phase 3
People
340 planned
Started
15 May 2023
Primary completion
5 Feb 2025
Arms
Direct Oral Anticoagulant
Results
None posted
  1. 24 Apr 2023: Trial registered
  2. 15 May 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.